ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 48 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $50,000 | -7.4% | 122,287 | +7.8% | 0.00% | – |
| Q1 2016 | $54,000 | -28.0% | 113,440 | +4.0% | 0.00% | – |
| Q4 2015 | $75,000 | -34.8% | 109,072 | -7.6% | 0.00% | -100.0% |
| Q3 2015 | $115,000 | -28.6% | 117,982 | -12.6% | 0.00% | 0.0% |
| Q2 2015 | $161,000 | +11.0% | 135,028 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $145,000 | +9.0% | 135,028 | +10.6% | 0.00% | 0.0% |
| Q4 2014 | $133,000 | +0.8% | 122,127 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $132,000 | -2.2% | 122,127 | -6.1% | 0.00% | 0.0% |
| Q2 2014 | $135,000 | +0.7% | 130,052 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $134,000 | -11.3% | 130,052 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $151,000 | -45.9% | 130,052 | -21.7% | 0.00% | -50.0% |
| Q3 2013 | $279,000 | – | 165,994 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ancora Advisors LLC | 50,000 | $20,000 | 0.00% |
| MONARCH CAPITAL MANAGEMENT INC/ | 10,000 | $4,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 122,287 | $50,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 254,200 | $103,000 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 47,998 | $19,000 | 0.00% |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 11,181 | $5,000 | 0.00% |
| Kistler-Tiffany Companies, LLC | 825 | $0 | 0.00% |
| Tradewinds Capital Management, LLC | 200 | $0 | 0.00% |
| NEXT Financial Group, Inc | 60 | $0 | 0.00% |
| CT Financial Advisors LLC | 2,000 | $810,000 | 0.00% |